Table 4 Classification of patients according to the crude score in the Derivation and Validation phase
Crude score | Derivation Number of patients (%) | Validation Number of patients (%) | ||||
|---|---|---|---|---|---|---|
Cases | Controls | Total | ESBL-PE | Non ESBL-PE | Total | |
0 | 0 (0) | 0 (0) | 0 | 2 (1) | 29 (3) | 31 |
1 | 3 (1) | 32 (7) | 35 | 22 (11) | 167 (20) | 189 |
2 | 13 (5) | 93 (20) | 106 | 56 (29) | 241 (30) | 297 |
3 | 68 (25) | 147 (33) | 215 | 47 (25) | 228 (28) | 275 |
4 | 93 (35) | 99 (22) | 192 | 35 (18) | 71 (9) | 106 |
5 | 61 (23) | 59 (13) | 120 | 22 (11) | 49 (6) | 71 |
6 | 24 (9) | 14 (3) | 38 | 4 (2) | 10 (1) | 14 |
7 | 3 (1) | 1 (0) | 4 | 0 (0) | 2 (0) | 2 |
Total | 265 | 445 | 710 | 188 | 797 | 985 |